Name | ARD-2051 |
---|
Description | ARD-2051 is a potent and orally active androgen receptor (AR) proteolysis-targeting chimera degrader. ARD-2051 achieves DC50 values of 0.6 nM for AR protein degradation in both the LNCaP and VCaP prostate cancer cell lines. ARD-2051 can be used for the research of prostate cancer[1]. |
---|---|
Related Catalog | |
Target |
DC50: 0.6 nM (AR protein degradation)[1] |
References |
Molecular Formula | C43H45ClN8O5 |
---|---|
Molecular Weight | 789.32 |